NATTO: BOARD MEMBER OF NATTOPHARMA ASA EXERCISE OPTIONS

Christopher von Schirach-Szmigiel, a board member in NattoPharma ASA, has exercised options granted to him in the Annual General Meeting in 2016.

Following the exercise of the option Mr. Schirach-Szmigiel will hold 50,000 shares and 50,000 options in NattoPharma ASA.

Based on the power of attorney granted at the annual general meeting of NattoPharma ASA on May 15, 2017, the Board of Directors of NattoPharma has in board proceedings May 8, 2018 approved a share issue of 50 000 new shares, each with a face value of NOK 3 per share.

Price to be paid for each share is NOK 8,78 per share. The share issue is expected to be completed within end of May 2018.

As a result, the share capital will be increased by NOK 150 000. After completing the share issue the Company’s new share capital will be NOK 54 539 799 divided into 18 179 933 shares, each with a face value of NOK 3.

* * *